Director received an award of 2,350 CTVA shares | OQRO
Why it stands out Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
Transaction date Apr 28, 2026
Reporting period Not applicable
Filed with the SEC May 1, 2026 Director Grant / award
Context Classification grant award
Code A — grant or award
Planned / mechanical clue Footnote references dividend reinvestment
Only flagged when a footnote says so; never inferred
Source receipt
Record ID 0001635634-26-000001
Filed / recorded
May 1, 2026, 1:38 AM UTC
Added to OQRO Oct 2, 2026, 12:27 PM UTC
Data quality Verified: identifiers matched exactly
Reporting person Janet Plaut Giesselman
Table Non-derivative (Table I)
Transaction date Apr 28, 2026
Acquired / disposed Acquired (A)
Shares owned after 20,006.9028
Footnotes from the filing Includes acquisition of 39.0792 shares pursuant to dividend reinvestment.
Around the same time 5mo ago
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
5mo ago
2 different filers disclosed CTVA within 90 days. Disclosed 18 days after the transaction; reported as an official range, not an exact amount.
5mo ago
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
Congress trade